Carol Sweeney, PhD

Languages spoken: English

Academic Information

Departments: Internal Medicine - Professor

Divisions: Epidemiology

Academic Office Information

carol.sweeney@hsc.utah.edu

Carol Sweeney, PhD, is a professor in the Division of Epidemiology, Department of Medicine at the University of Utah School of Medicine, an investigator at Huntsman Cancer Institute (HCI), and a member of the HCI Cancer Control and Population Sciences Program. She conducts research on cancer epidemiology, with specific interests in the role of common genetic variants in cancer susceptibility and survival and in the epidemiology of cancer survivors. She teaches epidemiology in the Research Education, Training, and Career Development core of the Utah Clinical and Translational Sciences Institute. She is director for operations and evaluation at the Utah Cancer Registry.

Sweeney received an MS degree in Environmental Health followed by a PhD in Epidemiology, both from the University of Washington. She completed a postdoctoral research fellowship in the Division of Molecular Epidemiology, National Center for Toxicological Research, U.S. Food and Drug Administration.

Education History

Postdoctoral Fellowship National Center for Toxicological Research
Molecular Epidemiology 		Postdoctoral Fellow
Doctoral Training University of Washington
Epidemiology 		Ph.D.
Graduate Training University of Washington
Environmental Health 		M.S.
Undergraduate Wellesley College
Biological Sciences 		B.A.

Selected Publications

  1. Millar MM, Edwards SL, Herget KA, Orleans B, Ofori-Atta BS, Kirchhoff AC, Carter ME, Nagata M, Sweeney C (2022). Adherence to Guideline-Recommended cancer screening among Utah cancer survivors. Cancer Med.
  2. Warner EL, Millar MM, Orleans B, Edwards SL, Carter ME, Vaca Lopez PL, Sweeney C, Kirchhoff AC (2022). Cancer survivors' financial hardship and their caregivers' employment: results from a statewide survey. J Cancer Surviv.
  3. Millar MM, Yoder V, Jozwik D, Espinoza J, Lemons D, Jewell CY, Sweeney C (2022). Improving Central Cancer Registry Surveillance through Interstate Data Exchange of Electronic Pathology Reports. J Registry Manag, 48(2), 59-63.
  4. Grossman D, Sweeney C, Doherty JA (2021). The Rapid Rise in Cutaneous Melanoma Diagnoses. [Letter to the editor]. N Engl J Med, 384(14), e54.
  5. Bowles TL, Sweeney C, Snyder J, Gygi J, Bott B, Wray D, Yeatman TJ, Sause WT (2021). Impact of rurality on melanoma diagnosis in Utah. Melanoma Manag, 8(2), MMT56.
  6. Gulbahce HE, White S, Herget KA, Stoddard G, Camp NJ, Buys SS, Sweeney C (2020). 21-gene recurrence score testing utilization among older women from different races: A population-based study. J Geriatr Oncol, 12(2), 206-211.
  7. Yuan Y, Van Dyke AL, Petkov VI, Hussey S, Moravec R, Altekruse SF, Sandoval M, Cress RD, Mueller LM, Mogi A, Hernandez BY, Selk FR, Lynch CF, Tucker TC, Lynch MA, Lefante C, Wu XC, Sweeney C, Doherty JA, Penberthy LS (2020). Pathology Laboratory Policies and Procedures for Releasing Diagnostic Tissue for Cancer Research. Arch Pathol Lab Med, 145(2), 222-226.
  8. Cho ME, Sweeney C, Fino N, Greene T, Ramkumar N, Huang Y, Ricardo AC, Shafi T, Deo R, Anderson A, Mills KT, Cheung AK, CRIC Study Investigators (2021). Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort. Am J Nephrol, 52(2), 141-151.
  9. Gallicchio L, Elena JW, Fagan S, Carter M, Hamilton AS, Hastert TA, Hunter LL, Li J, Lynch CF, Milam J, Millar MM, Modjeski D, Paddock LE, Reed AR, Moses LB, Stroup AM, Sweeney C, Trapido EJ, West MM, Wu XC, Helzlsouer KJ (2020). Utilizing SEER Cancer Registries for Population-Based Cancer Survivor Epidemiologic Studies: A Feasibility Study. Cancer Epidemiol Biomarkers Prev, 29(9), 1699-1709.
  10. Hanson HA, Leiser CL, Madsen MJ, Gardner J, Knight S, Cessna M, Sweeney C, Doherty JA, Smith KR, Bernard PS, Camp NJ (2020). Family Study Designs Informed by Tumor Heterogeneity and Multi-Cancer Pleiotropies: The Power of the Utah Population Database. Cancer Epidemiol Biomarkers Prev, 29(4), 807-815.
  11. Millar MM, Elena JW, Gallicchio L, Edwards SL, Carter ME, Herget KA, Sweeney C (2019). The feasibility of web surveys for obtaining patient-reported outcomes from cancer survivors: a randomized experiment comparing survey modes and brochure enclosures. BMC Med Res Methodol, 19(1), 208.
  12. Greenberg S, Buys SS, Edwards SL, Espinel W, Fraser A, Gammon A, Hafen B, Herget KA, Kohlmann W, Roundy C, Sweeney C (2019). Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing. Cancer Med, 8(15), 6789-6798.
  13. Hashibe M, Ou JY, Herget K, Bolton D, McPherson J, Hawley C, Garvin J, Doherty JA, Sweeney C (2019). Feasibility of Capturing Cancer Treatment Data in the Utah All-Payer Claims Database. JCO Clin Cancer Inform, 3, 1-10.
  14. Garvin JH, Herget KA, Hashibe M, Kirchhoff AC, Hawley CW, Bolton D, Sweeney C (2019). Linkage between Utah All Payers Claims Database and Central Cancer Registry. Health Serv Res, 54(3), 707-713.
  15. Millar MM, Kinney AY, Camp NJ, Cannon-Albright LA, Hashibe M, Penson DF, Kirchhoff AC, Neklason DW, Gilsenan AW, Dieck GS, Stroup AM, Edwards SL, Bateman C, Carter ME, Sweeney C (2019). Predictors of Response Outcomes for Research Recruitment Through a Central Cancer Registry: Evidence From 17 Recruitment Efforts for Population-Based Studies. Am J Epidemiol, 188(5), 928-939.
  16. Gulbahce HE, Bernard PS, Weltzien EK, Factor RE, Kushi LH, Caan BJ, Sweeney C (2018). Differences in molecular features of triple-negative breast cancers based on the age at diagnosis. Cancer, 124(24), 4676-4684.
  17. Petkov VI, Miller DP, Howlader N, Gliner N, Howe W, Schussler N, Cronin K, Baehner FL, Cress R, Deapen D, Glaser SL, Hernandez BY, Lynch CF, Mueller L, Schwartz AG, Schwartz SM, Stroup A, Sweeney C, Tucker TC, Ward KC, Wiggins C, Wu XC, Penberthy L, Shak S (2018). Erratum: Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study. NPJ Breast Cancer, 4, 17.
  18. Madsen MJ, Knight S, Sweeney C, Factor R, Salama M, Stijleman IJ, Rajamanickam V, Welm BE, Arunachalam S, Jones B, Rachamadugu R, Rowe K, Cessna MH, Thomas A, Kushi LH, Caan BJ, Bernard PS, Camp NJ (2018). Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15. Cancer Epidemiol Biomarkers Prev, 27(6), 644-652.
  19. AAlAbdulsalam AK, Garvin JH, Redd A, Carter ME, Sweeny C, Meystre SM (2018). Automated Extraction and Classification of Cancer Stage Mentions fromUnstructured Text Fields in a Central Cancer Registry. AMIA Jt Summits Transl Sci Proc, 2017, 16-25.
  20. Valenzuela LO, OGrady SP, Enright LE, Murtaugh M, Sweeney C, Ehleringer JR (2018). Evaluation of childhood nutrition by dietary survey and stable isotope analyses of hair and breath. Am J Hum Biol, 30(3), e23103.
  21. Hashibe M, Kirchhoff AC, Kepka D, Kim J, Millar M, Sweeney C, Herget K, Monroe M, Henry NL, Lopez AM, Mooney K (2018). Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah. Cancer Med, 7(4), 1490-1497.
  22. Gulbahce HE, Blair CK, Sweeney C, Salama ME (2017). Quantification of Estrogen Receptor Expression in Normal Breast Tissue in Postmenopausal Women With Breast Cancer and Association With Tumor Subtypes. Appl Immunohistochem Mol Morphol, 25(8), 548-552.
  23. Sweeney C, Baumgartner KB, Byers T, Giuliano AR, Herrick JS, Murtaugh MA, Slattery ML (2007). Reproductive history in relation to breast cancer risk among Hispanic and non-Hispanic white women. Cancer Causes Control, 19(4), 391-401.
  24. Lazovich D, Sweeney C, Weinstock MA, Berwick M (2004). Re: A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. [Letter to the editor]. J Natl Cancer Inst, 96(4), 335; author reply 337-8.